Techno Medica Co., Ltd.

As of March 31, 2026, Techno Medica Co., Ltd. carries a market capitalization of 15.59B, placing it among publicly traded companies globally. Its enterprise value stands at 6.62B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Techno Medica Co., Ltd.'s next confirmed earnings release is scheduled for November 6, 2026.

As of March 31, 2026, Techno Medica Co., Ltd. has 6.67M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Techno Medica Co., Ltd. maintains a current ratio of 5.09, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Techno Medica Co., Ltd.'s stock has gained approximately 9.20% over the past 52 weeks. The 50-day moving average sits at 2,053.06, while the 200-day moving average is 2,175.76.

These figures are as of March 31, 2026. Total book value stands at 14.41B, with working capital of 12.61B providing operational flexibility.

Techno Medica Co., Ltd.'s most recent stock split took place on September 26, 2013 with a 100:30003 split ratio.